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Abstract
Background: Rates of participation in Diabetes Prevention Programs (DPPs) are low. This may be due, in part, to
low levels of autonomous motivation (i.e., motivation that arises from internal sources and sustains healthy behaviors
over time) to prevent type 2 diabetes (T2DM) among many individuals with prediabetes. Mobile health (mHealth)
technologies that incorporate principles from the Self-Determination Theory offer an effective and scalable approach
to increase autonomous motivation levels. One promising mobile phone-based application is JOOL Health, which aims
to help users connect certain health behaviors (e.g., sleep and diet) with personal values in specific life domains (e.g.,
family and work). The first aim of this study is to estimate whether JOOL Health can increase autonomous motivation
to prevent T2DM among individuals with prediabetes who declined DPP participation. The second aim of this pilot
study is to examine the intervention’s feasibility and acceptability.
Methods: This is a 12-week, three-arm pilot randomized controlled trial. We will recruit 105 individuals with prediabetes
who did not engage in a DPP despite invitation from their health plan to participate in face-to-face or web-based
programs at no out-of-pocket-cost. Participants will be randomized to one of three study arms: (1) a group that
receives information on prediabetes, evidence-based strategies to decrease progression to T2DM, and a list of
resources for mHealth tools for monitoring diet, physical activity, and weight (comparison group); (2) a group that
receives the JOOL Health application; and (3) a group that receives the JOOL Health application as well as a Fitbit
activity tracker and wireless-enabled scale. Our primary outcome is change in autonomous motivation to prevent
T2DM (measured using the Treatment Self-Regulation Questionnaire). We will also collect data related to the
intervention’s feasibility (recruitment and retention rates) and acceptability (adherence and qualitative experience)
as well as changes in psychosocial outcomes, hemoglobin A1c, and weight.
Discussion: To our knowledge, this is the first study that aims to promote positive health behaviors among
individuals with prediabetes who previously declined to participate in a DPP. Our results will inform a larger trial
to test the effect of JOOL Health on clinically relevant outcomes, including weight loss, physical activity, and DPP
engagement.
Trial registration: NCT03025607. Registered February 2017.
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Background
Within the USA, type 2 diabetes mellitus (T2DM) and
its precursor, prediabetes, are growing public health con-
cerns. Approximately 84 million adults have prediabetes
[1], and it is estimated that one-third of the adult popu-
lation will have T2DM by 2050 [2]. Diabetes Prevention
Programs (DPPs) can promote modest weight loss [3–8]
to help individuals with prediabetes avoid progression to
T2DM [9–11], and these programs are available in
communities throughout the USA [4, 12].
Despite nationwide availability of the DPP [4] and
public health initiatives to identify and treat individuals
with prediabetes [13, 14], rates of DPP engagement are
extremely low [15]. Barriers to DPP participation include
logistical factors (e.g., transportation, time, cost) [16]
and behavioral factors (e.g., motivation, risk perception)
[17–19]. Although web-based DPPs [20, 21] and growing
insurance coverage for program participation [22–24]
can reduce logistical barriers, these strategies alone have
been inadequate to increase rates of DPP engagement.
In September 2015, for example, a single University’s
self-funded health insurers began to offer face-to-face
and online DPP options to healthcare plan members
(i.e., employees, retirees, and students of the University
or their dependents) with prediabetes at no out-of-
pocket-cost, yet only 6% of invitees enrolled in a DPP
within 6 months. Prior work demonstrates an associ-
ation between greater levels of autonomous motivation
and increased engagement in healthy behaviors among
this university’s employees with prediabetes [25]. This
finding, in combination with low levels of program
engagement, suggests that behavioral barriers may more
strongly influence rates of DPP participation than logis-
tical ones.
New strategies are needed to motivate individuals with
prediabetes to engage in healthy behaviors to prevent
T2DM. Mobile health (mHealth) technologies that in-
corporate principles from behavioral change theories
such as Self-Determination Theory (SDT) may be an
effective and highly scalable approach [26]. SDT pro-
vides a conceptual framework for understanding human
behavior across a continuum of motivation ranging from
controlled motivation to autonomous motivation [27]. In
contrast to controlled motivation, which originates from
a sense of external obligation or pressure, goals and be-
haviors are “autonomous” when they align with personal
interests and values [28]. Greater levels of autonomous
motivation correlate positively with dietary adherence
[29], weight loss [30, 31], physical activity [32, 33], and
DPP participation [34]. Importantly, autonomous behav-
iors are sustained over time [35, 36].
JOOL Health is a mobile phone-based health applica-
tion that aims to increase autonomous motivation by
helping users connect certain health behaviors (e.g.,
sleep, diet, physical activity) with personal values in
specific life domains (e.g., family and work) [37]. JOOL
Health integrates user-entered information with context-
ual data (e.g., weather and day of the week) and then
delivers tailored messages to help individuals gain aware-
ness of and control over the factors that contribute to
their well-being and ability to engage in self-care behav-
iors. In this way, JOOL Health aims to cultivate autono-
mous sources of motivation to initiate and maintain
healthy behaviors. Importantly, the JOOL Health
application has been tested among heterogeneous popu-
lations including healthy volunteers and individuals with
chronic diseases. These unpublished data demonstrate
high user engagement and statistically significant in-
creases in self-reported health behaviors.
We propose a pilot study to estimate the ability of
JOOL Health—used alone and also in conjunction with
Fitbit devices (i.e., activity tracker and wireless internet-
enabled scale)—to increase autonomous motivation to
prevent T2DM among individuals with prediabetes who
declined participation in a formal DPP (i.e., DPP non-
participants). Given that JOOL Health draws on SDT to
inspire behavioral change, we hypothesize that autono-
mous motivation to prevent T2DM will increase to a
greater degree among individuals who use JOOL Health
compared to individuals who only receive written educa-
tional materials about T2DM prevention. Because Fitbit
devices can also enhance user motivation by fostering
autonomy, competence, and relatedness (through shar-
ing of fitness data) [38]—key SDT tenets of psycho-
logical need—we also hypothesize that autonomous
motivation to prevent T2DM will increase to a greater
degree among individuals who use JOOL Health in con-
junction with Fitbit devices compared to individuals who
use the JOOL Health application alone. Further, we aim to
examine the feasibility of recruiting DPP non-participants
and the acceptability (adherence and qualitative experi-
ence as reported during semi-structured interviews) of the
intervention. We hypothesize that recruiting DPP non--
participants may have unique challenges, as these individ-
uals have already declined to participate in one lifestyle
intervention. However, as compared to the DPP, this is a
low-intensity intervention, which may appeal to individuals
seeking a less time-consuming program, and we believe
that study participants will find the intervention acceptable.
Taken together, these data will inform the design and im-
plementation of a larger trial to test the effect of JOOL
Health on clinically relevant outcomes, including weight
loss, physical activity, and DPP engagement.
Methods
This study was approved by the University of Michigan
Institutional Review Board. The protocol was designed ac-
cording to the Standard Protocol Items: Recommendations
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for Interventional Trials 2013 (SPIRIT). A SPIRIT figure
(Fig. 1) and SPIRIT checklist (Additional file 1) are
provided. The study is funded by the Blue Cross Blue
Shield of Michigan Foundation, and it is registered on
ClinicalTrials.gov (NCT03025607).
Study design
This study is a 12-week pilot randomized controlled
trial. Participants will be randomized to one of three
arms: (1) a group that receives information on prediabe-
tes and evidence-based ways to decrease progression to
T2DM as well as a list of resources for mHealth tools
for monitoring diet, physical activity, and weight (com-
parison); (2) a group that receives the same information
as group 1 and also the JOOL Health mobile phone ap-
plication (JOOL-only); and (3) a group that receives the
same information as group 1 and also the JOOL Health
mobile phone application and Fitbit devices (i.e., activity
tracker and wireless internet-enabled scale) whose re-
sults can be uploaded to JOOL Health (JOOL-plus). We
will use a mixed methods approach with a sequential ex-
planatory design, which is to say that quantitative data
and qualitative data will be collected in two consecutive
phases within the study [39]. Specifically, in the first
phase, we will collect and analyze the quantitative data
(e.g., surveys and weight). In the second phase, we will
collect and analyze qualitative, semi-structured interview
data from a purposive sample of 20 participants with
differing levels of engagement and success with the
intervention. The rationale for this approach is that the
qualitative data will help to clarify these findings by ex-
ploring participants’ experiences and perspectives in
more depth [40]. Additionally, through qualitative inter-
views, we will explore the acceptability of the JOOL
Fig. 1 Study flow diagram
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Health application among JOOL-only participants and
the acceptability of the JOOL Health application and
Fitbit devices among the JOOL-plus participants.
Study setting
The intervention will be delivered remotely. Individuals
in each arm of the study will receive study materials by
postal mail and/or e-mail. A study team member will be
available by telephone to help participants troubleshoot
technical issues that may arise with the study devices
and to address study-related questions or concerns.
Study participants
Inclusion criteria are (1) non-participation in a formal
DPP at least 6 months after invitation to participate by
the University’s self-funded insurers, Premier Care or
Grad Care; (2) prediabetes based on the American Dia-
betes Association criteria of hemoglobin A1c (HbA1c)
5.7 to 6.4%; (3) access to a personal smartphone; and (4)
access to home wireless internet. We will exclude
women who are pregnant or intend to become pregnant
during the intervention period. All eligible study partici-
pants are employees, retirees, and students of this
university or their dependents.
Recruitment
A member of the study team will contact by telephone a
random subset of Premier Care and Grad Care DPP
non-participants. Individuals interested in study partici-
pation will then be screened to ensure they meet study
eligibility criteria, and informed consent will be obtained
electronically using the RedCap survey platform [41].
Allocation
Individuals who meet study inclusion criteria and con-
sent to study participation will be randomized using a
web-based tool, the University of Michigan computer-
ized randomization system (TATUM—Treatment As-
signment Tool-UM), which allows for blinded treatment
allocation. We will use stratified randomization with
variable block lengths to ensure a balance of age and
gender between groups. Recruitment and randomization
will be ongoing until we have 35 individuals in each arm
of the study.
Intervention
All participants (N = 105) will receive information re-
garding prediabetes, evidence-based T2DM prevention
strategies, and mHealth resources to help monitor food
intake and composition, weight, and physical activity
(e.g., MyFitnessPal). All participants will be encouraged
to engage in self-monitoring and will be provided infor-
mation on the benefits of daily weighing and monitoring
of food and physical activity.
Participants in the JOOL-only and JOOL-plus arms
will receive instruction by e-mail on how to use their re-
spective mHealth applications. Participants in both inter-
vention arms will be asked to use JOOL Health on a
daily basis. JOOL Health will deliver tailored messages
to individuals based on the daily information they enter
in the following behavioral health domains: sleep, pres-
ence, activity, creativity, and eating. Additionally, the
tailored messaging will be informed by contextual factors
(e.g., local weather and day of the week). Participants in
the JOOL-plus arm will also be asked to perform daily
weights using a Fitbit wireless internet-enabled scale and
to wear a Fitbit physical activity tracker. These devices will
interface with the JOOL Health platform, and the data will
inform JOOL-delivered tailored messages.
Outcome measures
Primary outcome measures
The primary outcome will be change in autonomous
motivation to prevent T2DM. Autonomous motivation
will be measured using the seven-item, validated Treat-
ment Self-Regulation Questionnaire at baseline and 12-
week follow-up [42].
Secondary outcome measures
The feasibility of recruitment will be determined by calcu-
lating the intervention uptake rate, defined as the number
of participants recruited to the intervention divided by the
total number of eligible participants. Because we may not
be able to reach all eligible participants via telephone (e.g.,
disconnected phone line), we will also calculate the rate of
intervention uptake among only those for whom we are
able to contact. Reasons for non-participation in this study
will be recorded.
Among JOOL-only and JOOL-plus participants, we will
calculate rates of adherence to the JOOL Health applica-
tion, defined as the number of app-usage days (defined as
the number of days that users entered data into JOOL
Health) divided by the total number of days during the
intervention period. Among JOOL-plus participants, we
will calculate rates of participant adherence to the Fitbit
activity tracker and scale, defined as the number of total
days that each of these devices were used divided by the
total number of days during the intervention period.
Participant retention will be determined by calculating
the completion rate for the 12-week survey.
The acceptability of the intervention will be deter-
mined through semi-structured interviews conducted via
telephone. Following the intervention period, we will
conduct semi-structured interviews with JOOL-only and
JOOL-plus participants. For purposive sampling, we will
interview individuals with differing levels of engagement
with the intervention and change in autonomous motiv-
ation using cut-points for high and low levels of these
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determined following quantitative data analysis. We will
conduct at least 20 interviews divided equally between
JOOL-only and JOOL-plus participants; additional inter-
views will be conducted if we do not reach thematic
saturation after 20 interviews [43, 44]. During the inter-
views, we will explore the following: reasons participants
chose to engage in this study; participants’ experience
with the JOOL Health application; and participants’ ex-
periences with the Fitbit activity tracker and scale, if ap-
plicable. In this way, we will gain insight into the
particular intervention characteristics (or combination of
characteristics) that may have facilitated or hindered the
participants’ ability to achieve the primary outcome. We
will also solicit participants’ ideas regarding additional
behavioral change supports and their recommendations
on ways to improve the intervention.
We will evaluate change in HbA1c; baseline HbA1c
will be abstracted from the electronic medical record
and participants will be asked to have a follow-up
HbA1c drawn after the 12-week intervention period.
Additional exploratory outcomes will include change in
the following self-reported measures: weight (kg) and/or
BMI (kg/m2); change in overall level of motivation to
prevent T2DM [34]; purpose in life [45, 46]; perceived
competence to prevent type 2 diabetes [47]; social sup-
port [48]; eating behavior [49]; self-reported physical ac-
tivity [50]; patient activation [51]; and willingness to
participate in a Diabetes Prevention Program. We will
collect these exploratory data at baseline and 12-weeks
using survey instruments, which will be administered
using RedCap, a secure web application [52]. At baseline,
we will also collect sociodemographic characteristics in-
cluding age, gender, race, ethnicity, education, and in-
come. Among JOOL Health users, we will also evaluate
changes in charted daily health behaviors (e.g., sleep, eat-
ing, physical activity) from baseline (first 2 weeks of the
intervention) to 12-weeks (last 2 weeks of the interven-
tion). Among participants in the JOOL-plus arm, we will
also assess objective change in physical activity minutes
and body weight as measured with the Fitbit activity
tracker and scale from baseline (first 2 weeks of the
intervention) to 12-weeks (last 2 weeks of the interven-
tion). Because the Fitbit devices interface with the JOOL
Health platform, Fitbit data will be stored within the
JOOL Health application. At the end of the study period,
the JOOL Health team will provide our study team with
a comma-separated values (CSV) file containing raw
data from the JOOL app and Fitbit devices.
Sample size
Based on prior studies of autonomous motivation among
University of Michigan employees [34], we anticipate
that the baseline level of autonomous motivation to pre-
vent T2DM among Premier Care or Grad Care members
who decline DPP participation will be 5.7 (measured on
a 1 to 7 scale with 1 being the lowest and 7 being the
highest). During the 12-week intervention period, we an-
ticipate that autonomous motivation will increase by 0.6
points in the JOOL-only arm and by 0.8 points in the
JOOL-plus arm. Assuming a standard deviation of 1.0
for change in autonomous motivation in both arms, 29
participants in each arm will provide 80% power to de-
tect these changes in autonomous motivation in the
intervention arms compared to the comparison arm.
Prior research demonstrates that a 0.5-point increase in
autonomous motivation can lead to greater weight loss
and increased physical activity compared to individuals
who did not achieve this increase in autonomous motiv-
ation [36]. To account for the possibility that some par-
ticipants may be lost to follow-up during our 12-week
intervention, we have conservatively inflated our sample
size by 20% to enroll 35 participants in each arm.
Data analysis
For all continuous outcomes, we will calculate changes
from baseline to 12 weeks. For each continuous out-
come, we will then conduct two sample t tests to deter-
mine whether the mean change for that outcome was
statistically significantly different for each intervention
arm relative to the comparison arm. For all categorical
outcomes, we will use chi-square or Fisher’s exact tests
to between-arm changes from baseline to 12 weeks.
While we will be conducting multiple tests for statistical
significance, we will not adjust our threshold for statis-
tical significance (e.g., using a Bonferroni correction) for
multiple comparisons so as to avoid making a type II
error in this pilot study. We will conduct all analyses
using Stata 14.
Semi-structured interviews will be audio recorded and
subsequently transcribed verbatim. Interviews will then
be imported into qualitative analysis software. Two in-
vestigators will independently read and code transcribed
interviews. Interviews will then be coded jointly using
consensus conferences. Interviews will be analyzed using
directed content analysis [53].
Consistent with a mixed-methods sequential explana-
tory design [40], we will integrate (i.e., connect) the quan-
titative and qualitative findings in the final stage of data
analysis. In this way, we will interpret our quantitative
data in the context of qualitative participant experience.
Discussion
Evidence-based Diabetes Prevention Programs are avail-
able in communities across the USA and can effectively
promote weight loss among individuals with prediabetes
[12]. However, the DPP alone may be insufficient to im-
prove population health, as low rates of participation
limit the program’s reach. Prior studies have described
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determinants of participation [17] and non-participation
[16, 54, 55] in lifestyle-change programs, as well as bar-
riers to adherence among those who initially engage in
these programs [19]. However, it is unknown whether
interventions to increase levels of autonomous motiva-
tion—a key driver of lifestyle change among individuals
with prediabetes [25]—can promote healthy behaviors
and greater rates of DPP engagement among individuals
with prediabetes.
In this pilot study, we aim to test whether JOOL Health
can increase autonomous motivation among individuals
with prediabetes when used alone and also in conjunction
with other mHealth tools. Because changes in individuals’
levels of autonomous motivation occur early along the
path to behavioral change, we anticipate a large effect size
from the intervention and will therefore have the power to
detect between-group differences in this outcome in the
context of a relatively small study (N = 105). This will
serve as an important indicator that a larger study may
lead to measurable changes in clinically relevant health
outcomes such was body weight, physical activity, and
DPP engagement. It is also possible that we will not detect
changes in autonomous motivation. For this reason, we
will conduct qualitative interviews with study participants
so that we can interpret our quantitative findings in the
context of individual-level participant experiences. For ex-
ample, it is possible that some individuals may desire add-
itional support (e.g., brief counseling, nutritional advice,
explicit exercise goals) to augment the JOOL Health ex-
perience. Some individuals may want more tailored mes-
saging from the JOOL Health application while others
may find the daily charting to be burdensome. Under-
standing participants’ experiences will enable us to refine
and strengthen our program. In this way, we will tailor
our intervention to better meet the individual-level needs
of this previously overlooked population with prediabetes
who have not engaged in a formal DPP.
Importantly, we will also gain new insight into the
feasibility of recruiting a target population that is pre-
sumed to be difficult to engage based on extremely low
rates of uptake in offered DPP options. However, it is
plausible that some individuals, although reluctant to
engage in a year-long DPP, may be interested in a lower-
intensity program such as this mHealth intervention.
Relatively high levels of engagement in this intervention
may suggest that this population is not as difficult to
reach as presumed. Rather, tailored strategies and varied
options to encourage weight loss and increased physical
activity may be needed to help such individuals prevent
type 2 diabetes. In contrast, relatively low levels of en-
gagement may confirm our suspicion that this is truly a
difficult population to engage, and we could then con-
sider focus groups and/or interviews with key stake-
holders to explore best practices for engagement.
This study has several important potential limitations.
First, this is, to our knowledge, the first study to test a
behavioral change program among individuals who pre-
viously declined DPP participation despite being invited
to participate in either an in-person or web-based option
at no out-of-pocket-cost. Accordingly, it is difficult to
predict rates of recruitment or adherence among this
population, as these individuals may be more reluctant
to make lifestyle changes than the general population,
and additional strategies may be necessary to encourage
participation. We will thus collect data about the inter-
vention’s feasibility and acceptability, and we will apply
learned lessons to the subsequent larger study. Second,
despite numerous mHealth applications to promote be-
havioral change and chronic disease management, rates
of engagement with these applications over time are low
[56], and use of mHealth devices may have unpredictable
effects on the behaviors and outcomes they aim to mod-
ify [57, 58]. It is unknown whether study participants
will engage with JOOL Health or whether use of the app
will stimulate positive behavioral change among the
study population. Encouragingly, JOOL Health possesses
key features associated with app effectiveness (e.g., user-
friendly design, real-time feedback, and individualized
messages) [59], which we believe will facilitate app use
and promote healthy behaviors. Lastly, our study popu-
lation will only include members of the University of
Michigan’s self-funded insurance plans, which may limit
the generalizability of our findings. To minimize this
limitation, we will recruit from a random sample of
health plan beneficiaries with prediabetes, which in-
cludes over 20,000 employees, dependents, and retirees.
To reduce the public health burden of prediabetes and
T2DM, novel strategies are needed to promote healthy
behaviors among individuals with prediabetes. The infor-
mation gathered through this study will inform subse-
quent work to identify clinically effective, cost-effective,
and highly-scalable approaches to prevent or delay the
onset of T2DM and enhance the population health im-
pact of existing Diabetes Prevention Programs.
Additional file
Additional file 1: SPIRIT checklist. (PDF 122 kb)
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